TCTR20231003007进行中（未招募）不适用
Antiphospholipid antibodies testing and pregnancy outcomes in recurrent implantation failure women, is it necessary?
/A0 个研究点目标入组 250 人开始时间: 2023年10月3日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 50 Years（—）
- 性别
- Female
入选标准
- •Women with recurrent implantation failure (more than 2 times)
排除标准
- •Women with a history of thrombosis
- •Women diagnosed antiphospholipid syndrome
- •Women with uncorrected anatomical abnormalities
- •Women with uncontrolled autoimmune diseases
- •Women with uncontrolled endocrine disorders
- •Women who have an abnormal karyotype
- •Women who treated with anticaogulant
研究者
相似试验
已完成
不适用
Antiphospholipid syndrome in pregnancy: A controlled treatment trialPregnancyantiphospholipid antibody syndromePregnancy and ChildbirthOther maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperiumISRCTN55179279HS R&D Regional Programme Register - Department of Health (UK)98
尚未招募
不适用
Antiphospholipid Antibody (APLA) level in COVID-19 Cases.CTRI/2020/06/026118DR Rajlaxmi Sarangi
招募中
不适用
AntiPhosphoLipid antibodies and point-of-care INR measurement with CoaguChek - VervOlg Studie100644771000381610014523Antiphospholipid syndromeNL-OMON56632niversitair Medisch Centrum Utrecht44
Unknown
不适用
Antiphospholipid Antibodies and Fetal Growth RestrictionAntiphospholipid SyndromeFetal Growth RestrictionNCT01538134Saint Thomas Hospital, Panama90
Unknown
不适用
Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy ControlsIschemic StrokeNCT01487746Meir Medical Center207